VEGFA and cancer: Moreover, we have shown that the antiangiogenic effect of everolimus correlates not only with the reduction of VEGF by cancer cells but also with a direct inhibitory effect on endothelial cells, as proven by its ability to inhibit HUVEC proliferation and tubular formation alone and in combination with gefitinib.